These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4152854)

  • 21. [Modern achievements in the field of catecholamine biochemistry].
    Gorkin VZ
    Vopr Med Khim; 1974 May; 20(3):227-38. PubMed ID: 4152064
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.
    Agarwal DP; Hoo JJ; Tjaden A; Nishigaki I; Beckermann WJ; Pahnke V; Goedde HW
    Arzneimittelforschung; 1985; 35(11):1639-42. PubMed ID: 2936351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
    Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
    Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?
    Singhal RL; Rastogi RB; Lapierre YD
    J Neural Transm; 1983; 56(2-3):127-38. PubMed ID: 6306165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional changes in [3H]-noradrenaline uptake, catecholamines and catecholamine synthetic and catabolic enzymes in rat brain following neonatal 6-hydroxydopamine treatment.
    Jonsson G; Sachs C
    Med Biol; 1976 Aug; 54(4):286-97. PubMed ID: 8670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for different sites of monoamine oxidase and catechol-O-methyltransferase in the striatum.
    Tokunaga K; Ishikawa K
    Brain Res; 1992 Mar; 575(1):164-6. PubMed ID: 1504778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptics-induced changes of tyrosine hydroxylase activity in rat striatum in vitro and in vivo.
    Honma T; Hirose A
    Life Sci; 1979 May; 24(22):2023-30. PubMed ID: 37397
    [No Abstract]   [Full Text] [Related]  

  • 28. Metabolism of monoamines in malignant hyperthermia-susceptible pigs.
    Bardsley ME; Wheatley AM; Fowler CJ; McCrodden JM; McLoughlin JV; Tipton KF
    Br J Anaesth; 1982 Dec; 54(12):1313-8. PubMed ID: 7171419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of catecholamine enzymes in vas deferens during nerve stimulation.
    Bhagat B; Dave T; Lee YC; Bryan RJ
    Am J Physiol; 1973 Jan; 224(1):46-9. PubMed ID: 4405151
    [No Abstract]   [Full Text] [Related]  

  • 30. The action of neuroleptics in rats with altered catecholamine metabolism. II. The effects of chlorpromazine, haloperidol, and thioridazine on brain noradrenaline content elevated by previous administration of MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):53-64. PubMed ID: 4775864
    [No Abstract]   [Full Text] [Related]  

  • 31. Activities of enzymes involved in the formation and destruction of biogenic amines in various areas of human brain.
    Vogel WH; Orfei V; Century B
    J Pharmacol Exp Ther; 1969 Feb; 165(2):196-203. PubMed ID: 5763056
    [No Abstract]   [Full Text] [Related]  

  • 32. The regional and subcellular distribution of catechol-O-methyl transferase in the rat brain.
    Broch OJ; Fonnum F
    J Neurochem; 1972 Sep; 19(9):2049-55. PubMed ID: 4403687
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic amines.
    Berkowitz BA
    Eur J Pharmacol; 1974 May; 26(2):359-65. PubMed ID: 4152866
    [No Abstract]   [Full Text] [Related]  

  • 34. Consequences of monoamine oxidase inhibition: increased vesicular accumulation of dopamine and norepinephrine and increased metabolism by catechol-O-methyltransferase and phenolsulfotransferase.
    Buu NT; Lussier C
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):563-8. PubMed ID: 2748880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of caerulein with haloperidol on monoamine contents in rat brain regions treated with methamphetamine.
    Hashimoto M; Hirai T; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1986 May; 41(1):127-30. PubMed ID: 3735809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress.
    Lidbrink P; Corrodi H; Fuxe K; Olson L
    Brain Res; 1972 Oct; 45(2):507-24. PubMed ID: 4404488
    [No Abstract]   [Full Text] [Related]  

  • 38. The fate of noradrenaline in the sympathetic neurone.
    Axelrod J
    Harvey Lect; 1973; 67():175-97. PubMed ID: 4145715
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of catechol-O-methyl transferase inhibitors on behavior and dopamine metabolism.
    McKenzie GM
    Adv Biochem Psychopharmacol; 1974; 12(0):339-51. PubMed ID: 4419524
    [No Abstract]   [Full Text] [Related]  

  • 40. Chronic neuroleptic therapy: tolerance and GABA systems.
    Lloyd KG; Shibuya M; Davidson L; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1977; 16():409-15. PubMed ID: 18890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.